Sub Banner Image

Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills

Market Impact

Chandrima Sanyal

·

July 26, 2025

·

Benzinga

Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.

read more

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.